beta

ACER

Acer Therapeutics Inc.

Acer

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Acer Therapeutics Inc is a pharmaceutical company that acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need.

Market Cap: 143 Million

Primary Exchange: NASDAQ Capital Market

Website: https://www.acertx.com

Shares Outstanding: 7.5 Million

Float: 2.05 Million

Dividend: 0.0 (0.0%)

Beta: 2.519044

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 43.9 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1689 trading days

From: 2013-02-05 To: 2019-10-18

Lowest Point:

Acer Therapeutics: Concerns Prior To Upcoming PDUFA Date

via: SeekingAlpha at 2019-06-11 12:00:30:000

Acer Therapeutics Inc. (ACER) ("Acer" or the "Company") is a pharmaceutical company headquartered in Newton, Massachusetts, focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening orphan or ultra-orphan diseases with significant unmet… read more...

Acer Therapeutics: Concerns Prior To Upcoming PDUFA Date

via: SeekingAlpha at 2019-06-11 12:00:30:000

Acer Therapeutics Inc. (ACER) ("Acer" or the "Company") is a pharmaceutical company headquartered in Newton, Massachusetts, focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening orphan or ultra-orphan diseases with significant unmet… read more...

Acer Therapeutics: Concerns Prior To Upcoming PDUFA Date

via: SeekingAlpha at 2019-06-11 12:00:30:000

Acer Therapeutics Inc. (ACER) ("Acer" or the "Company") is a pharmaceutical company headquartered in Newton, Massachusetts, focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening orphan or ultra-orphan diseases with significant unmet… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-09-21 10.355527 1.0 10.355527
2015-09-29 8.0 1.0 8.0
Data provided by IEX Cloud